Association of functional DBH genetic variants with alcohol dependence risk and related depression and suicide attempt phenotypes: Results from a large multicenter association study

Drug and Alcohol Dependence

Volumn 133, Issue 2, 2013, Pages 459-467

  Preuss, U W ^a   Wurst, F M ^d   Ridinger, M ^c   Rujescu, D ^a,b   Fehr, C ^e   Koller, G ^b   Bondy, B ^b   Wodarz, N ^c   Soyka, M ^b,f   Zill, P ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f Privatklinik Meiringen ^*  (Switzerland)

Author keywords

Alcohol dependence; Alcohol dependence and depression; Association genetic variants; DBH genetic variants; Gender differences; Suicide attempt history

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADULT; ALCOHOLISM; ALLELE; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DBH GENE; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMANY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW; SUICIDE ATTEMPT;

ALCOHOL DEPENDENCE; ALCOHOL DEPENDENCE AND DEPRESSION; ASSOCIATION GENETIC VARIANTS; DBH GENETIC VARIANTS; GENDER DIFFERENCES; SUICIDE ATTEMPT HISTORY;

ADULT; AGE OF ONSET; ALCOHOLISM; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; DNA; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERMANY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; SAMPLE SIZE; SEX CHARACTERISTICS; SUICIDE, ATTEMPTED;

EID: 84887024898     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.07.002     Document Type: Article

References (75)

1. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955, 11:375-386.
2. Avery C.L., Martin L.J., Williams J.T., North K.E. Accuracy of haplotype estimation in a region of low linkage disequilibrium. BMC Genet. 2005, 6(Suppl. l):S80.
3. Ballenger J.C., Goodwin F.K., Major L.F., Brown G.L. Alcohol and central serotonin metabolism in man. Arch. Gen. Psychiatry 1979, 36:224-227.
4. Bierut L.J., Agrawal A., Bucholz K.K., Doheny K.F., Laurie C., Pugh E., Fisher S., Fox L., Howells W., Bertelsen S., Hinrichs A.L., Almasy L., Breslau N., Culverhouse R.C., Dick D.M., Edenberg H.J., Foroud T., Grucza R.A., Hatsukami D., Hesselbrock V., Johnson E.O., Kramer J., Krueger R.F., Kuperman S., Lynskey M., Mann K., Neuman R.J., Nöthen M.M., Nurnberger J.I., Porjesz B., Ridinger M., Saccone N.L., Saccone S.F., Schuckit M.A., Tischfield J.A., Wang J.C., Rietschel M., Goate A.M., Rice J.P. Gene, environment association studies consortium. A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A 2010, 107:5082-5087.
5. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., Lubar J.O., Chen T.J., Comings D.E. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoactive Drugs 2000, 32(Suppl. I-IV):1-112.
6. Bourdélat-Parks B.N., Anderson G.M., Donaldson Z.R., Weiss J.M., Bonsall R.W., Emery M.S., Liles L.C., Weinshenker D. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) 2005, 183:72-80.
7. Bowirrat A., Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 132B:29-37.
8. Bucholz K.K., Cadoret R., Cloninger C.R., Dinwiddie S.H., Hesselbrock V.M., Nurnberger J.I., Reich T., Schmidt I., Schuckit M.A. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994, 55:49-58.
9. Chignon J.M., Cortes M.J., Martin P., Chabannes J.P. Attempted suicide and alcohol dependence: results of an epidemiologic survey. Encephale 1998, 24:347-354.
10. Cubells J.F., Price L.H., Meyers B.S., Anderson G.M., Zabetian C.P., Alexopoulos G.S., Nelson J.C., Sanacora G., Kirwin P., Carpenter L., Malison R.T., Gelernter J. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol. Psychiatry 2002, 51:358-364.
11. Cubells J.F., Sun X., Li W., Bonsall R.W., McGrath J.A., Avramopoulos D., Lasseter V.K., Wolyniec P.S., Tang Y.L., Mercer K., Pulver A.E., Elston R.C. Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia. Hum Genet 2011, 130:635-643.
12. De Luca V., Mueller D.J., Tharmalingam S., King N., Kennedy J.L. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol. Psychiatry 2004, 9:896-897.
13. De Luca V., Voineskos D., Wong G.W., Shinkai T., Rothe C., Strauss J., Kennedy J.L. Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality. Psychiatry Res. 2005, 134:195-198.
14. D'Souza U.M., Craig I.W. Functional polymorphisms in dopamine and serotonin pathway genes. Hum Mutat 2006, 27:1-13.
15. Driessen M., Veltrup C., Weber J., John U., Wetterling T., Dilling H. Psychiatric co-morbidity, suicidal behaviour and suicidal ideation in alcoholics seeking treatment. Addiction 1998, 93:889-894.
16. Duan J., Sanders A.R., Molen J.E., Martinolich L., Mowry B.J., Levinson D.F., Crowe R.R., Silverman J.M., Gejman P.V. Polymorphisms in the 5'-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression. Mol. Psychiatry 2003, 8:901-910.
17. Dynacom Inc Ltd. 2007. SNPAlyze Version 6, User Guide, Kanagawa Yokohama, Japan.
18. Eisemann M., Ericsson U., Von Knorring L., Perris C., Perris H., Ross S. Serum dopamine-beta-hydroxylase in diagnostic subgroups of depressed patients and in relation to their personality characteristics. Neuropsychobiology 1983, 9:193-196.
19. Faul F., Erdfelder E., Lang A.G., Buchner A. G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
20. Fahndrich E., Muller-Oerlinghausen B., Coper H. Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression. Int. Pharmacopsychiatry 1982, 17:8-17.
21. Freire M.T., Marques F.Z., Hutz M.H., Bau C.H. Polymorphisms in the DBH and DRD2 gene regions and smoking behavior. Eur Arch Psychiatry Clin Neurosci 2006, 256:93-97.
22. Freire M.T., Hutz M.H., Bau C.H. The DBH-1021C/T polymorphism is not associated with alcoholism but possibly with patients' exposure to life events. J. Neural Transm. 2005, 112:1269-1274.
23. Fydrich T., Renneberg B., Schmitz B., Wittchen H.U. SCID-II. Structured Clinical Interview II for DSM-IV. Axis II: Personality Disorders 1997, Hogrefe, Interviewheft Göttingen.
24. Gibb B.E., McGeary J.E., Beevers C.G., Mille r I.W. Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide Life Threat. Behav. 2006, 36:687-693.
25. Gorwood P., Batel P., Adès J., Hamon M., Boni C. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 2000, 48:259-264.
26. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg-proportion for multiple alleles. Biometrics 1992, 48:361-372.
27. Hawi Z., Lowe N., Kirley A., Gruenhage F., Nöthen M., Greenwood T., Kelsoe J., Fitzgerald M., Gill M. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 2003, 8:299-308.
28. Heath A.C., Bucholz K.K., Madden P.A., Dinwiddie S.H., Slutske W.S., Beirut D.J., Statham D.J., Donne M.P., Whitfield J.B., Martin N.G. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol. Med. 1997, 27:1381-1384.
29. Hess C., Reif A., Strobel A., Boreatti-Hümmer A., Heine M., Lesch K.P., Jacob C.P. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 2009, 116:121-130.
30. Hodge C.W. Comparison of the discriminative stimulus function of ethanol following intracranial and systemic administration: evidence of a central mechanism. Pharmacol Biochem Behav 1994, 47:743-747.
31. Hoyle G.W., Mercer E.H., Palmiter R.D., Brinster R.L. Cell-specific expression from the human dopamine beta-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements. J. Neurosci. 1994, 14:2455-2463.
32. Inskip H.M., Harris E.C., Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br. J. Psychiatry 1998, 172:35-37.
33. Johann M., Putzhammer A., Eichhammer P., Wodarz N. Association of the -141C Del variant of the dopamine D2 receptor (DRD2) with positive family history and suicidality in German alcoholics. Am J Med Genet B Neuropsychiatr Genet 2005, 5(132B):46-49.
34. Kelley A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 2002, 22:3306-3311.
35. Kessler R.C., Borges G., Walters E.E. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch. Gen. Psychiatry 1999, 56:617-626.
36. Kim C.Y., Zabetian C.P., Cubells J.F., Cho S., Biaggioni I., Cohen B.M., Robertson D., Kim K.S. Mutations in the dopamine β- hydroxylase gene are associated with human dopamine β- hydroxylase deficiency. Am J Med Genet 2002, 108:140-147.
37. Kohnke M.D., Zabetian C.P., Anderson G.M., Kolb W., Gaertner I., Buchkremer G., Vonthein R., Schick S., Lutz U., Kohnke A.M., Cubells J.F. A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function. Biol. Psychiatry 2002, 52:1151-1158.
38. Levitt M., Dunner D.L., Mendlewicz J., Frewin D.B., Lawlor W., Fleiss J.L., Stallone F., Fieve R.R. Plasma dopamine beta hydroxylase activity in affective disorders. Psychopharmacologia 1976, 46:205-210.
39. Lewontin R.C. On measures of gametic disequilibrium. Genetics 1988, 120:849-852.
40. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int J Neuropsychopharmacol 2006, 9:465-474.
41. Mann J.J., Brent D.A., Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 2001, 24:467-477.
42. Mann J.J., Currier D., Murphy L., Huang Y.Y., Galfalvy H., Brent D., Greenhil l L., Oquendo M. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover. J. Affect. Disord. 2008, 106:117-121.
43. Markianos E., Beckmann H. Diurnal changes in dopamine-β-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man. J Neural Transm 1976, 39:79-93.
44. Mathew R.J., Ho B.T., Davis C., Taylor D., Reck J. Depression, antidepressants, and plasma DBH. Psychiatry Res. 1981, 5:331-334.
45. Matuzas W., Meltzer H.Y., Uhlenhuth E.H., Glass R.M., Tong C. Plasma dopamine-beta-hydroxylase in depressed patients. Biol. Psychiatry 1982, 17:1415-1424.
46. Meyers B.S., Alexopoulos G.S., Kakuma T., Tirumalasetti F., Gabriele M., Alpert S., Bowden C., Meltzer H.Y. Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression. Biol. Psychiatry 1999, 45:448-452.
47. Mod L., Rihmer Z., Magyar I., Arato M., Alfoldi A., Bagdy G. Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression. Psychiatry Res. 1986, 19:331-333.
48. Nielsen D.A., Goldman D., Virkkunen M., Tokola R., Rawlings R., Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiat 1994, 51:34-38.
49. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003, 28:1546-1552.
50. Oxenstierna G., Edman G., Iselius L., Oreland L., Ross S.B., Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals-a genetic study. J. Psychiatr. Res. 1986, 20:19-29.
51. Pfeffer A.O., Samson H.H. Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats. Pharmacol Biochem Behav 1988, 29:343-350.
52. Preuss U.W., Schuckit M.A., Smith T.L., Danko G.P., Bucholz K.K., Hesselbrock M.N., Hesselbrock V., Kramer J.R. Predictors and correlates of suicide attempts over 5 years in 1,237 alcohol-dependent men and women. Am. J. Psychiatry 2003, 160:56-63.
53. Preuss U.W., Schuckit M.A., Smith T.L., Danko G.P., Buckman K., Bierut L., Bucholz K.K., Hesselbrock M.N., Hesselbrock V.M., Reich T. Comparison of 3190 alcohol-dependent individuals with and without suicide attempts. Alcohol. Clin. Exp. Res. 2002, 26:471-477.
54. Preuss U.W., Schuckit M.A., Smith T.L., Danko G.R., Dasher A.C., Hesselbrock M.N., Hesselbrock V.M., Nurnberger J.I. A comparison of alcohol-induced and independent depression in alcoholics with histories of suicide attempts. J. Stud. Alcohol 2002, 63:498-502.
55. Puzynski S., Rode A., Zaluska M. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression. Acta Psychiatr. Scand. 1983, 67:89-95.
56. Redgrave P., Gurney K. The short-latency dopamine signal: a role in discovering novel actions?. Nat. Rev. Neurosci. 2006, 7:967-975.
57. Rice J.P., Reich T., Bucholz K.K., Neuman R.J., Fishman R., Rochberg N., Hesselbrock V.M., Nurnberger J.I., Schuckit M.A., Begleiter H. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol. Clin. Exp. Res. 1995, 19:1018-1023.
58. Roy A., Brockington K. Plasma dopamine-beta-hydroxylase in depressed patients and controls. Neuropsychobiology 1987, 18:57-59.
59. Sapru M.K., Rao B.S., Channabasavanna S.M. Serum dopaminebeta-hydroxylase activity in clinical subtypes of depression. Acta Psychiatr. Scand. 1989, 80:474-478.
60. Schuckit M.A., Li T.K., Cloninger C.R., Deitrich R.A. Genetics of alcoholism. Alcohol Clin Exp Res 1985, 9:476-492.
61. Strandman E., Wetterberg L., Perris C., Ross S.B. Serum dopamine-beta-hydroxylase in affective disorders. Neuropsychobiology 1978, 4:248-255.
62. Sun H.F., Chang Y.T., Fann C.S., Chang C.J., Chen Y.H., Hsu Y.P., Yu W.Y., Cheng A.T. Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han. Biol. Psychiatry 2002, 51:896-901.
63. Tamatam A., Khanum F., Bawa A.S. Genetic biomarkers of depression. Indian J Hum Genet 2012, 18:20-33.
64. Treutlein J., Rietschel M. Genome-wide association studies of alcohol dependence and substance use disorders. Curr. Psychiatry Rep. 2011, 13:147-155.
65. Virkkunen M., Rawlings R., Tokola R., Poland R.E., Guidotti A., Nemeroff C., Bissette G., Kalogeras K., Karonen S.L., Linnoila M. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch. Gen. Psychiatry 1994, 51:20-27.
66. Wang S., Zhang K., Xu Y., Sun N., Shen Y., Xu Q. An association study of the serotonin transporter and receptor genes with the suicidal ideation of major depression in a Chinese Han population. Psychiatry Res. 2009, 170:204-207.
67. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:887-893.
68. Wittchen, H.U., Pfister, H., 2004. DIA-X-Interviews: Manual for Screening Procedures and Interview. Interview block for longitudinal studies (DIA-X-Lifetime).
69. Wittchen H.U., Lachner G., Wunderlich U., Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc. Psychiatry Psychiatr. Epidemiol. 1998, 11:568-578.
70. Zabetian C.P., Anderson G.M., Buxbaum S.G., Elston R.C., Ichinose H., Nagatsu T., Kim K.S., Kim C.H., Malison R.T., Gelernter J., Cubells J.F. A quantitative-trait analysis of human plasma dopamine β-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 2001, 68:515-522.
71. Zabetian C.P., Buxbaum S.G., Elston R.C., Köhnke M.D., Anderson G.M., Gelernter J., Cubells J.F. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine β-hydroxylase activity. Am. J. Hum. Genet. 2003, 72:1389-1400.
72. Zai C.C., de Luca V., Strauss J., Tong R.P., Sakinofsky I., Kennedy J.L. Genetic factors and suicidal behavior. The Neurobiological Basis of Suicide 2012, CRC Press, Boca Raton, FL. Y. Dwivedi (Ed.).
73. Zill P., Preuss U.W., Koller G., Bondy B., Soyka M. SNP- and haplotype analysis of the tryptophan hydroxylase 2 gene in alcohol-dependent patients and alcohol-related suicide. Neuropsychopharmacology 2007, 32:1687-1694.
74. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., Moller H.J., Bondy B., Ackenheil M. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 2004, 9:1030-1036.
75. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 2004, 56:581-586.